Filter
496
Filtered Results: 496
Text search:
Rational
Pharmaceutical
Management
Project
Featured
Recommendations
39
New Publications
160
Language
Document type
No document type
275
Studies & Reports
89
Guidelines
66
Strategic & Response Plan
24
Manuals
21
Training Material
12
Situation Updates
7
Fact sheets
2
Countries / Regions
Kenya
26
Ethiopia
22
Global
16
Zambia
16
India
16
Uganda
15
Nigeria
14
Western and Central Europe
13
Namibia
11
Ghana
10
Tanzania
10
Liberia
10
Rwanda
9
Philippines
9
Nepal
8
Sierra Leone
8
Eastern Europe
8
Malawi
7
Cambodia
6
Myanmar / Burma
6
Lesotho
5
Latin America and the Carribbean
5
Bangladesh
5
South Africa
5
Eswatini/ Swaziland
5
Africa
4
Indonesia
4
Thailand
3
Ukraine
3
Cameroon
3
Zimbabwe
3
Asia
3
Congo, Democratic Republic of
3
South–East Asia Region
3
Botswana
3
South Sudan
3
China
2
Mozambique
2
Haiti
2
Germany
2
Eastern Europe and Central Asia
2
Vietnam
2
North Macedonia
1
Tajikistan
1
Benin
1
Syria
1
Albania
1
Laos
1
Senegal
1
Burkina Faso
1
Peru
1
USA
1
Jordan
1
Western Pacific Region
1
Gabon
1
Turkmenistan
1
Belgium
1
Russia
1
Sudan
1
Central African Republic
1
Mali
1
Libya
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
229
Clinical Guidelines
27
Key Resources
26
Public Health
23
Pharmacy & Technologies
10
Women & Child Health
8
Capacity Building
3
Annual Report MEDBOX
2
Toolboxes
AMR
74
Pharmacy
46
TB
31
Mental Health
17
HIV
16
NTDs
13
NCDs
12
Rapid Response
9
COVID-19
9
Global Health Education
9
Planetary Health
8
Caregiver
7
2.0 Rapid Response
5
Ebola & Marburg
4
Health Financing Toolbox
4
Malaria
4
Refugee
3
Natural Hazards
3
Conflict
3
Disability
2
Polio
2
Specific Hazards
1
Zika
1
The Health Sector Policy gives general orientations for the sector which are further developed in the various sub-sector policies guiding key health programs and departments. All health sub-sector policies will be updated in line with this new policy. The Health Sector Policy is the basis of nationa...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
Recognition, Assessment and Treatment
National Clinical Guideline Number 159
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para...
Zambia has about 1.2 physicians, nurses, and midwives per 1000 population while the minimum acceptable density threshold is 2.3 per 1000 population. The estimated shortage of doctors, nurses and midwives in Zambia is about 14,960. However, with the projected population growth the deficit more than d...
Assessment Report
Southern Med Review (2009)2;1:2-6
In line with its decentralization principle, the Ethiopian Health Policy has achieved great progress in improving access to comprehensive HIV/AIDS services to the majority of the population. Both quality and coverage of services have improved significantlysince the initiation...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
This is the first NAP on the Prevention and Containment of AMR in Kenya. It has been developed based on the National Policy on Prevention and Containment of AMR and the recommendations of the situation analysis on AMR conducted in 2011 and updated in 2016. This strategy provides a regulatory and imp...
